Transaction Valuation*
|
Amount of Filing Fee** | ||
$2,978,902,500
|
$91,452.31 | ||
* | Estimated for purposes of calculating the filing fee only. This amount assumes the purchase of all 33,668,000 shares of common stock of Ventana Medical Systems, Inc. (Ventana) outstanding as of March 31, 2007, all options outstanding as of March 31, 2007 with respect to 6,022,000 shares of common stock of Ventana, and all restricted stock and restricted stock units outstanding as of March 31, 2007 with respect to 28,700 shares of common stock of Ventana. The number of outstanding shares, options, and restricted stock and restricted stock units is contained in Ventanas Quarterly Report on Form 10-Q for the quarter ended March 31, 2007. | |
** | The amount of the filing fee is calculated in accordance with Rule 0-11 of the Securities Exchange Act of 1934, as amended, by multiplying the transaction valuation by 0.0000307. |
o | Check box if any part of the fee is offset as provided by Rule 0-11(a)(2) and identify the filing with which the offsetting fee was previously paid. Identify the previous filing by registration statement number, or the Form or Schedule and the date of its filing. |
Amount Previously Paid:
|
Not applicable. | Filing Party: | Not applicable. | |||
Form or Registration No.:
|
Not applicable. | Date Filed: | Not applicable. | |||
o | Check the box if the filing relates solely to preliminary communications made before the commencement of a tender offer. |
þ | third-party tender offer subject to Rule 14d-1 | |
o | issuer tender offer subject to Rule 13e-4 | |
o | going-private transaction subject to Rule 13e-3 | |
o | amendment to Schedule 13D under Rule 13d-2 |
Item 10. | Financial Statements. |
Item 12. | Exhibits. |
Exhibit No.
|
Description
|
|||
(a)(1)(i) | Offer to Purchase dated June 27, 2007. | |||
(a)(1)(ii) | Letter of Transmittal. | |||
(a)(1)(iii) | Notice of Guaranteed Delivery. | |||
(a)(1)(iv) | Letter to Brokers, Dealers, Commercial Banks, Trust Companies and Other Nominees. | |||
(a)(1)(v) | Letter to Clients for use by Brokers, Dealers, Commercial Banks, Trust Companies and Other Nominees. | |||
(a)(1)(vi) | Guidelines for Certification of Taxpayer Identification Number on Substitute Form W-9. | |||
(a)(1)(vii) | Summary Advertisement dated June 27, 2007. | |||
(a)(5)(i) | Press Release issued by Roche Holding Ltd, dated June 27, 2007. | |||
(b) | Not applicable. | |||
(c) | Not applicable. | |||
(d) | Not applicable. | |||
(f) | Not applicable. | |||
(g) | Not applicable. | |||
(h) | Not applicable. |
Exhibit No.
|
Description
|
|||
(a)(1)(i) | Offer to Purchase dated June 27, 2007 | |||
(a)(1)(ii) | Letter of Transmittal | |||
(a)(1)(iii) | Notice of Guaranteed Delivery | |||
(a)(1)(iv) | Letter to Brokers, Dealers, Commercial Banks, Trust Companies and Other Nominees | |||
(a)(1)(v) | Letter to Clients for use by Brokers, Dealers, Commercial Banks, Trust Companies and Other Nominees | |||
(a)(1)(vi) | Guidelines for Certification of Taxpayer Identification Number on Substitute Form W-9 | |||
(a)(1)(vii) | Summary Advertisement dated June 27, 2007 | |||
(a)(5)(i) | Press Release issued by Roche Holding Ltd, dated June 27, 2007 | |||
(b) | Not applicable | |||
(c) | Not applicable | |||
(d) | Not applicable | |||
(f) | Not applicable | |||
(g) | Not applicable | |||
(h) | Not applicable |